CTRI/2024/08/071931招募中3 期
Evaluation of efficacy and safety of Aptivate syrup in children with non-specific anorexia – An open label, randomized, comparative, multicentric, interventional, prospective clinical study - NI
upin Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Children diagnosed with Poor Appetite and Digestion without any underlying pathological condition without any significant weight loss over the last 3 months
- •2. Children having Eating Disorders falling in the criteria of - Unspecified Feeding or Eating Disorders as per DSM 5 TR criteria: (This category applies to presentations in which symptoms characteristic of a feeding and eating disorder that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any of the disorders in the feeding and eating disorders diagnostic class. The unspecified feeding or eating disorder category is used in situations in which the clinician chooses not to specify the reason that the criteria are not met for a specific feeding and eating disorder and includes presentations in which there is insufficient information to make a more specific diagnosis
排除标准
- •1. Children with chronic illnesses and taking medications for the same or congenital abnormalities
- •2. Children who are currently taking any medications for appetite stimulation or digestive disorders
- •3. Children who have used any investigational product 1 month prior to screening in the present study
- •4. Children taking systemic antibiotics for any infection
- •5. Children with known metabolic and/or endocrine disorder/s
- •6. Children with any type of known GI tract disorder (including mal-absorption syndrome, etc.)
- •7. Children with known Liver and Renal disorders
- •8. Children with known immunological, hematologic disorders, neurological or
- •psychiatric pathologies
- •9. Children with known hypersensitivity to herbal ingredients used in the study product or in general to any herbal product
- •10. Any other condition due to which children are deemed to be unsuitable by investigator for reason(s) not specifically stated in the exclusion criteria
研究者
相似试验
尚未招募
2 期
Evaluation of Safety and Efficacy of a Herbo mineral Formulation for increasing Hemoglobin and Iron Deficiency AnaemiaCTRI/2024/03/064617Dabur India Pvt Ltd
已完成
3 期
Study of Ayurvedic formulation in Diabetic Kidney Disease.CTRI/2018/04/013063Dr Aparna Sathe99
已完成
2 期
Clinical Study on AyuAsmo Capsules in AsthmaCTRI/2018/04/012980Welex Laboratories Pvt Ltd
已完成
4 期
To study the effectiveness and safety of artesunate + sulphadoxine- pyrimethamine in patients with uncomplicated falciparum malariaCTRI/2011/091/000047Govt Medical College60
招募中
不适用
A pilot study of efficacy and safety of aprepitant with chemoradiotherapy involving weekly cisplatin in patients with cervical cancer.cervical cancerJPRN-UMIN000003979ara Medical University30
